Resistant hypertension: comparing hemodynamic management to specialist care.
about
Current approaches to renovascular hypertensionMineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!Mineralocorticoid Receptor Antagonists for Treatment of Hypertension and Heart FailureRefractory and Resistant Hypertension: Antihypertensive Treatment Failure versus Treatment ResistanceOrthostatic Circulatory Disorders: From Nosology to Nuts and Bolts.Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure.Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.Treatment resistant hypertension--investigation and conservative managementIndividualizing antihypertensive combination therapies: clinical and hemodynamic considerations.Individualizing hypertension treatment with impedance cardiography: a meta-analysis of published trials.Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.Resistant hypertension workup and approach to treatmentCan nocturnal hypertension predict cardiovascular risk?Hypertension in people with type 2 diabetes: Update on pharmacologic management.Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure.Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertensionMonotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trialRefractory hypertension: definition, prevalence, and patient characteristics.The association between medication adherence and treatment intensification with blood pressure control in resistant hypertensionResistant hypertension in type 2 diabetes: prevalence and patients characteristics.Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trialResistant or difficult-to-treat hypertension.Impedance cardiographic hemodynamic variables and hypertension in elderly Han residents.A "patient-tailored" treatment of hypertension with use of impedance cardiography: a randomized, prospective and controlled trialShort-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study.Hypertension in diabetes: a call to action.The uncertain value of renal artery interventions: where are we now?2009 Canadian Hypertension Education Program recommendations: an annual update.Management of patients with resistant hypertension: current treatment options.Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansionThe role of noninvasive hemodynamic monitoring in the evaluation and treatment of hypertension.New techniques for assessment of vascular function.Nocturnal blood pressure profiles among normotensive, controlled hypertensive and refractory hypertensive subjectsCurrent options for the treatment of resistant hypertension.Reduction of blood pressure in patients with treatment-resistant hypertension.Drug therapy for resistant hypertension: simplifying the approach.Central sympatholytic drugs.Epidemiology, prognosis, and treatment of resistant hypertension.How will the growing threat of resistant hypertension impact the future treatment of high blood pressure?
P2860
Q24646720-8A61913A-2F43-4A8F-8444-3917D80C57EEQ26776149-E4CBF9FE-783A-4B5C-95AC-14AA831BF73EQ28066549-AB7A29DA-8E8C-4601-BDC7-0240A3F5674AQ28078151-58085EC3-4B83-44B2-BA57-8BC33424D848Q33167003-CE9BE423-E774-4D5F-84E6-3D4AFFE0EC75Q33658284-3F96FD68-4A9E-46B0-9531-840F4418F530Q33789175-B52B7CF6-E493-419C-A349-AF0CF9C8BF5FQ33892370-4DDAAC90-F94C-4C40-9E22-AE21A9C17AE3Q34068478-F4009640-FD4D-430D-871A-9F59BC9761F8Q34090470-498A7AA7-F1BE-4803-9D6D-529E59ECCAB2Q34299778-29650818-C04A-47DB-A2B9-621945753135Q34460704-0BFC88D2-EFF3-4489-9E47-92C2CCB07EF9Q35210578-6E291F03-54B0-4135-82A1-F4BB23495914Q35213902-D1E04EF7-0757-47CD-A6B8-8BC5C94EAE1DQ35533435-47EA6C4E-695B-4285-843C-14C7CF212E17Q35738038-CA753D37-FDC7-41E9-9EB3-A4919F3ECA76Q35959952-C2AC203B-B784-484F-8A56-CF62EEDE703DQ35963836-C5683F69-69D4-4063-B290-C1C7A792831DQ36104595-C0701A71-A89D-46D9-B25E-A9928FF7F890Q36178338-E0A39CC0-738A-4440-A51A-4D5300AEC1FFQ36247763-80602976-CC75-4748-BB73-7601D4FB83D6Q36305422-56384D9E-6FD7-4E58-B55D-F98899B1227EQ36416109-C0E21600-A5CE-4ACF-8B76-4CBBF51DA3A1Q36787112-A4805946-4E15-41F7-9D39-04616522904EQ36859492-3295C621-0C6C-45A3-A704-B31310E13D9CQ37184413-D8FC15F5-C83D-48BC-A530-D8B1DEDE8FBEQ37253892-C864069E-5AA5-4167-B999-8DF9082D9370Q37269888-B4CC293A-3E9F-45FD-80A6-38830A61864FQ37281600-29AE81C9-8F7A-40F7-B88C-768BE6D48A37Q37304418-13CD5886-31FB-4456-9B60-BDAD30D1942BQ37356547-AB466478-1348-4ED5-B43F-51D1C52FC26AQ37362695-3BB58E1A-CBA6-4857-9967-1A27F16501CDQ37362771-DBED7B8B-5CD0-4D56-A99E-3F56D4C6B3E2Q37429292-D233CDAB-C04D-4644-B5FB-5381977E14E8Q37629838-8ADB3BC7-E560-47BA-A4B0-6B66CFED2EBFQ37635112-29D65366-0552-4F2D-B5FC-B757A45C4AA9Q37832774-F335BA52-BD0E-45F0-AE31-8699FD1D014BQ37928130-7D0E8291-F435-49EA-8860-86D5805893FEQ38110711-34B0C6EF-4F03-4B10-BCC1-7B9DCF9B1D84Q38154609-880BB31B-8C7C-477E-9966-FB221CA5911A
P2860
Resistant hypertension: comparing hemodynamic management to specialist care.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Resistant hypertension: comparing hemodynamic management to specialist care.
@en
Resistant hypertension: comparing hemodynamic management to specialist care.
@nl
type
label
Resistant hypertension: comparing hemodynamic management to specialist care.
@en
Resistant hypertension: comparing hemodynamic management to specialist care.
@nl
prefLabel
Resistant hypertension: comparing hemodynamic management to specialist care.
@en
Resistant hypertension: comparing hemodynamic management to specialist care.
@nl
P2093
P1433
P1476
Resistant hypertension: comparing hemodynamic management to specialist care.
@en
P2093
Jo Ellen Augustine
Sandra J Taler
Stephen C Textor
P304
P356
10.1161/01.HYP.0000016176.16042.2F
P407
P577
2002-05-01T00:00:00Z